As of September 29, 2026, Royalty Pharma's top three insider holders are 1978 Sicaf Sif S.A. Gg (TenPercentOwner, 22.08Mn shares), 1978 Sicaf Sif S.A. - Gg Strategic Gg (TenPercentOwner, 21.43Mn shares), Mario Germano Giuliani (Director, 7.80Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | 1978 Sicaf Sif S.A. Gg | TenPercentOwner | 0 | 22,081,156 | 22,081,156 | 44.2% | 16 Sep, 2022 |
| 2 | 1978 Sicaf Sif S.A. - Gg Strategic Gg | TenPercentOwner | 0 | 21,426,170 | 21,426,170 | 42.9% | 22 Sep, 2022 |
| 3 | Management Ltd Avara | TenPercentOwner | 0 | 2,477,520 | 2,477,520 | 5.0% | 03 Jan, 2024 |
| 4 | Pablo G. Legorreta | Ceo, Chairman Of The Board | 1,307,820 | 600,000 | 1,907,820 | 3.8% | 07 Aug, 2026 |
| 5 | James F. Reddoch | Evp Chief Scientific Officer | 0 | 820,800 | 820,800 | 1.6% | 30 Sep, 2022 |
| 6 | Rory B Riggs | Director | 320,099 | 0 | 320,099 | 0.6% | 22 Feb, 2024 |
| 7 | Christopher Hite | Evp Chairman, Partnering | 0 | 270,401 | 270,401 | 0.5% | 24 Sep, 2026 |
| 8 | Gregory Norden | Director | 196,348 | 0 | 196,348 | 0.4% | 08 Jun, 2026 |
| 9 | Errol B Desouza | Director | 81,352 | 0 | 81,352 | 0.2% | 14 May, 2025 |
| 10 | Bonnie L Bassler | Director | 79,181 | 0 | 79,181 | 0.2% | 30 Jun, 2026 |
| 11 | Henry A Fernandez | Director | 65,324 | 0 | 65,324 | 0.1% | 30 Jun, 2025 |
| 12 | Ted W Love | Director | 58,393 | 0 | 58,393 | 0.1% | 08 Jun, 2026 |
| 13 | Catherine M. Engelbert | Director | 55,673 | 0 | 55,673 | 0.1% | 08 Jun, 2026 |
| 14 | David C Hodgson | Director | 37,873 | 0 | 37,873 | 0.1% | 08 Jun, 2026 |
| 15 | Vlad Coric | Director | 15,343 | 0 | 15,343 | 0.0% | 08 Jun, 2026 |
| 16 | Elizabeth H Weatherman | Director | 13,103 | 0 | 13,103 | 0.0% | 08 Jun, 2026 |
| 17 | Marshall Urist | Evp, Research Investments | 8,252 | 0 | 8,252 | 0.0% | 07 Aug, 2026 |
| 18 | Mario Germano Giuliani | Director, TenPercentOwner | 7,747 | 0 | 7,747 | 0.0% | 27 Jun, 2023 |
| 19 | George W. Lloyd | Evp, Investments Clo | 0 | 6,084 | 6,084 | 0.0% | 19 Dec, 2025 |
| 20 | Carole Ho | Director | 4,545 | 0 | 4,545 | 0.0% | 08 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 22 Sep, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 96,073 | $58.51 | $5.62Mn | 274,328 | Indirect |
| 22 Sep, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 3,927 | $58.93 | $231.40K | 270,401 | Indirect |
| 18 Aug, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 100,000 | $59.97 | $6.00Mn | 370,401 | Indirect |
| 19 Aug, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed G | 16,800 | $0.00 | $0 | 23,200 | Direct |
| 13 Aug, 2026 | Terrance P. Coyne | Evp Cfo | Disposed S | 9,230 | $58.59 | $540.75K | 1,772 | Indirect |
| 13 Aug, 2026 | Terrance P. Coyne | Evp Cfo | Disposed S | 1,772 | $59.14 | $104.80K | 0 | Indirect |
| 05 Aug, 2026 | Christopher Hite | Evp Chairman, Partnering | Acquired A | 11,002 | $0.00 | $0 | 470,401 | Indirect |
| 05 Aug, 2026 | Pablo G. Legorreta | Ceo, Chairman Of The Board | Acquired A | 65,216 | $0.00 | $0 | 1,307,820 | Direct |
| 05 Aug, 2026 | Marshall Urist | Evp, Research Investments | Acquired A | 8,252 | $0.00 | $0 | 8,252 | Direct |
| 05 Aug, 2026 | Terrance P. Coyne | Evp Cfo | Acquired A | 11,002 | $0.00 | $0 | 11,002 | Indirect |
| 07 Aug, 2026 | Marshall Urist | Evp, Research Investments | Disposed G | 3,000 | $0.00 | $0 | 244,412 | Indirect |
| 07 Aug, 2026 | Terrance P. Coyne | Evp Cfo | Disposed G | 18,500 | $0.00 | $0 | 1,788,777 | Indirect |
| 07 Aug, 2026 | Pablo G. Legorreta | Ceo, Chairman Of The Board | Disposed G | 30,000 | $0.00 | $0 | 662,701 | Direct |
| 30 Jun, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 97,446 | $56.50 | $5.51Mn | 461,953 | Indirect |
| 01 Jul, 2026 | Marshall Urist | Evp, Research Investments | Disposed S | 9,099 | $55.88 | $508.45K | 0 | Direct |
| 30 Jun, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 2,554 | $57.10 | $145.84K | 459,399 | Indirect |
| 30 Jun, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 29,400 | $56.44 | $1.66Mn | 40,600 | Direct |
| 30 Jun, 2026 | Christopher Hite | Evp Chairman, Partnering | Disposed S | 600 | $57.09 | $34.25K | 40,000 | Direct |
| 30 Jun, 2026 | Bonnie L Bassler | Director | Acquired A | 689 | $54.40 | $37.48K | 79,181 | Direct |
| 24 Jun, 2026 | Marshall Urist | Evp, Research Investments | Disposed S | 9,098 | $55.18 | $502.07K | 9,099 | Direct |